The Market Reports

Index

1 Basiliximab Injection Market Overview
1.1 Product Overview and Scope of Basiliximab Injection
1.2 Basiliximab Injection Segment by Dosage Type
1.2.1 Global Basiliximab Injection Sales Growth Rate Comparison by Dosage Type (2021-2027)
1.2.2 20 mL
1.2.3 10 mL
1.3 Basiliximab Injection Segment by Application
1.3.1 Global Basiliximab Injection Sales Comparison by Application: (2021-2027)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.4 Global Basiliximab Injection Market Size Estimates and Forecasts
1.4.1 Global Basiliximab Injection Revenue 2016-2027
1.4.2 Global Basiliximab Injection Sales 2016-2027
1.4.3 Basiliximab Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Basiliximab Injection Market Competition by Manufacturers
2.1 Global Basiliximab Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Basiliximab Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Basiliximab Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Basiliximab Injection Manufacturing Sites, Area Served, Product Type
2.5 Basiliximab Injection Market Competitive Situation and Trends
2.5.1 Basiliximab Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Basiliximab Injection Players Market Share by Revenue
2.5.3 Global Basiliximab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Basiliximab Injection Retrospective Market Scenario by Region
3.1 Global Basiliximab Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Basiliximab Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Basiliximab Injection Market Facts & Figures by Country
3.3.1 North America Basiliximab Injection Sales by Country
3.3.2 North America Basiliximab Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Basiliximab Injection Market Facts & Figures by Country
3.4.1 Europe Basiliximab Injection Sales by Country
3.4.2 Europe Basiliximab Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Basiliximab Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Basiliximab Injection Sales by Region
3.5.2 Asia Pacific Basiliximab Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Basiliximab Injection Market Facts & Figures by Country
3.6.1 Latin America Basiliximab Injection Sales by Country
3.6.2 Latin America Basiliximab Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Basiliximab Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Basiliximab Injection Sales by Country
3.7.2 Middle East and Africa Basiliximab Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Basiliximab Injection Historic Market Analysis by Dosage Type
4.1 Global Basiliximab Injection Sales Market Share by Dosage Type (2016-2021)
4.2 Global Basiliximab Injection Revenue Market Share by Dosage Type (2016-2021)
4.3 Global Basiliximab Injection Price by Dosage Type (2016-2021)

5 Global Basiliximab Injection Historic Market Analysis by Application
5.1 Global Basiliximab Injection Sales Market Share by Application (2016-2021)
5.2 Global Basiliximab Injection Revenue Market Share by Application (2016-2021)
5.3 Global Basiliximab Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Basiliximab Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis AG Basiliximab Injection Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Ryvis Pharma
6.2.1 Ryvis Pharma Corporation Information
6.2.2 Ryvis Pharma Description and Business Overview
6.2.3 Ryvis Pharma Basiliximab Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Ryvis Pharma Basiliximab Injection Product Portfolio
6.2.5 Ryvis Pharma Recent Developments/Updates

7 Basiliximab Injection Manufacturing Cost Analysis
7.1 Basiliximab Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Basiliximab Injection
7.4 Basiliximab Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Basiliximab Injection Distributors List
8.3 Basiliximab Injection Customers

9 Basiliximab Injection Market Dynamics
9.1 Basiliximab Injection Industry Trends
9.2 Basiliximab Injection Growth Drivers
9.3 Basiliximab Injection Market Challenges
9.4 Basiliximab Injection Market Restraints

10 Global Market Forecast
10.1 Basiliximab Injection Market Estimates and Projections by Dosage Type
10.1.1 Global Forecasted Sales of Basiliximab Injection by Dosage Type (2022-2027)
10.1.2 Global Forecasted Revenue of Basiliximab Injection by Dosage Type (2022-2027)
10.2 Basiliximab Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Basiliximab Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Basiliximab Injection by Application (2022-2027)
10.3 Basiliximab Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Basiliximab Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Basiliximab Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Basiliximab Injection Sales (KL) Growth Rate Comparison by Dosage Type (2021-2027)
Table 2. Global Basiliximab Injection Sales (KL) Comparison by Application (2021-2027)
Table 3. Global Basiliximab Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Basiliximab Injection Covered in This Study
Table 5. Global Basiliximab Injection Sales (KL) of Key Manufacturers (2016-2021)
Table 6. Global Basiliximab Injection Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Basiliximab Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Basiliximab Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Basiliximab Injection Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Basiliximab Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Basiliximab Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Basiliximab Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basiliximab Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Basiliximab Injection Sales by Region (2016-2021) & (KL)
Table 16. Global Basiliximab Injection Sales Market Share by Region (2016-2021)
Table 17. Global Basiliximab Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Basiliximab Injection Sales by Country (2016-2021) & (KL)
Table 19. North America Basiliximab Injection Sales Market Share by Country (2016-2021)
Table 20. North America Basiliximab Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Basiliximab Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Basiliximab Injection Sales by Country (2016-2021) & (KL)
Table 23. Europe Basiliximab Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Basiliximab Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Basiliximab Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Basiliximab Injection Sales by Region (2016-2021) & (KL)
Table 27. Asia Pacific Basiliximab Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Basiliximab Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Basiliximab Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Basiliximab Injection Sales by Country (2016-2021) & (KL)
Table 31. Latin America Basiliximab Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Basiliximab Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Basiliximab Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Basiliximab Injection Sales by Country (2016-2021) & (KL)
Table 35. Middle East and Africa Basiliximab Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Basiliximab Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Basiliximab Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Basiliximab Injection Sales (KL) by Dosage Type (2016-2021)
Table 39. Global Basiliximab Injection Sales Market Share by Dosage Type (2016-2021)
Table 40. Global Basiliximab Injection Revenue (Million US$) by Dosage Type (2016-2021)
Table 41. Global Basiliximab Injection Revenue Share by Dosage Type (2016-2021)
Table 42. Global Basiliximab Injection Price (US$/L) by Dosage Type (2016-2021)
Table 43. Global Basiliximab Injection Sales (KL) by Application (2016-2021)
Table 44. Global Basiliximab Injection Sales Market Share by Application (2016-2021)
Table 45. Global Basiliximab Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Basiliximab Injection Revenue Share by Application (2016-2021)
Table 47. Global Basiliximab Injection Price (US$/L) by Application (2016-2021)
Table 48. Novartis AG Corporation Information
Table 49. Novartis AG Description and Business Overview
Table 50. Novartis AG Basiliximab Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Novartis AG Basiliximab Injection Product
Table 52. Novartis AG Recent Developments/Updates
Table 53. Ryvis Pharma Corporation Information
Table 54. Ryvis Pharma Description and Business Overview
Table 55. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. Ryvis Pharma Basiliximab Injection Product
Table 57. Ryvis Pharma Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Basiliximab Injection Distributors List
Table 61. Basiliximab Injection Customers List
Table 62. Basiliximab Injection Market Trends
Table 63. Basiliximab Injection Growth Drivers
Table 64. Basiliximab Injection Market Challenges
Table 65. Basiliximab Injection Market Restraints
Table 66. Global Basiliximab Injection Sales Forecast by Dosage Type (2022-2027) & (KL)
Table 67. Global Basiliximab Injection Sales Market Share Forecast by Dosage Type (2022-2027)
Table 68. Global Basiliximab Injection Revenue Forecast by Dosage Type (2022-2027) & (US$ Million)
Table 69. Global Basiliximab Injection Revenue Market Share Forecast by Dosage Type (2022-2027)
Table 70. Global Basiliximab Injection Sales Forecast by Application (2022-2027) & (KL)
Table 71. Global Basiliximab Injection Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Basiliximab Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Basiliximab Injection Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Basiliximab Injection Sales Forecast by Region (2022-2027) & (KL)
Table 75. Global Basiliximab Injection Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Basiliximab Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Basiliximab Injection Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Basiliximab Injection
Figure 2. Global Basiliximab Injection Market Share by Dosage Type in 2020 & 2027
Figure 3. 20 mL Product Picture
Figure 4. 10 mL Product Picture
Figure 5. Global Basiliximab Injection Market Share by Application in 2020 & 2027
Figure 6. Adult Use
Figure 7. Pediatric Use
Figure 8. Global Basiliximab Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Basiliximab Injection Market Size 2016-2027 (US$ Million)
Figure 10. Global Basiliximab Injection Sales 2016-2027 (KL)
Figure 11. Global Basiliximab Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Basiliximab Injection Sales Share by Manufacturers in 2020
Figure 13. Global Basiliximab Injection Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Basiliximab Injection Players: Market Share by Revenue in 2020
Figure 15. Basiliximab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Basiliximab Injection Sales Market Share by Region (2016-2021)
Figure 17. Global Basiliximab Injection Sales Market Share by Region in 2020
Figure 18. Global Basiliximab Injection Revenue Market Share by Region (2016-2021)
Figure 19. Global Basiliximab Injection Revenue Market Share by Region in 2020
Figure 20. United States Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Taiwan Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Mexico Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Brazil Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Argentina Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Colombia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Basiliximab Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Basiliximab Injection by Dosage Type (2016-2021)
Figure 44. Sales Market Share of Basiliximab Injection by Application (2016-2021)
Figure 45. Sales Market Share of Basiliximab Injection by Application in 2020
Figure 46. Revenue Share of Basiliximab Injection by Application (2016-2021)
Figure 47. Revenue Share of Basiliximab Injection by Application in 2020
Figure 48. Manufacturing Cost Structure of Basiliximab Injection
Figure 49. Manufacturing Process Analysis of Basiliximab Injection
Figure 50. Basiliximab Injection Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed